Literature DB >> 24893049

Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.

Harriet C Thoeny1, Johannes M Froehlich, Maria Triantafyllou, Juerg Huesler, Lauren J Bains, Peter Vermathen, Achim Fleischmann, Urs E Studer.   

Abstract

PURPOSE: To prospectively assess the diagnostic performance of diffusion-weighted (DW) magnetic resonance (MR) imaging in the detection of pelvic lymph node metastases in patients with prostate and/or bladder cancer staged as N0 with preoperative cross-sectional imaging.
MATERIALS AND METHODS: This study was approved by an independent ethics committee. Written informed consent was obtained from all patients. Patients with no enlarged lymph nodes on preoperative cross-sectional images who were scheduled for radical resection of the primary tumor and extended pelvic lymph node dissection were enrolled. All patients were examined with a 3-T MR unit, and examinations included conventional and DW MR imaging of the entire pelvis. Image analysis was performed by three independent readers blinded to any clinical information. Metastases were diagnosed on the basis of high signal intensity on high b value DW MR images and morphologic features (shape, border). Histopathologic examination served as the standard of reference. Sensitivity and specificity were calculated, and bias-corrected 95% confidence intervals (CIs) were obtained with the bootstrap method. The Fleiss and Cohen κ and median test were applied for statistical analyses.
RESULTS: A total of 4846 lymph nodes were resected in 120 patients. Eighty-eight lymph node metastases were found in 33 of 120 patients (27.5%). Short-axis diameter of these metastases was less than or equal to 3 mm in 68, more than 3 mm to 5 mm in 13, more than 5 mm to 8 mm in five; and more than 8 mm in two. On a per-patient level, the three readers correctly detected metastases in 26 (79%; 95% CI: 64%, 91%), 21 (64%; 95% CI: 45%, 79%), and 25 (76%; 95% CI: 60%, 90%) of the 33 patients with metastases, with respective specificities of 85% (95% CI: 78%, 92%), 79% (95% CI: 70%, 88%), and 84% (95% CI: 76%, 92%). Analyzed according to hemipelvis, lymph node metastases were detected with histopathologic examination in 44 of 240 pelvic sides (18%); the three readers correctly detected these on DW MR images in 26 (59%; 95% CI: 45%, 73%), 19 (43%; 95% CI: 27%, 57%), and 28 (64%; 95% CI: 47%, 78%) of the 44 cases.
CONCLUSION: DW MR imaging enables noninvasive detection of small lymph node metastases in normal-sized nodes in a substantial percentage of patients with prostate and bladder cancer diagnosed as N0 with conventional cross-sectional imaging techniques. © RSNA, 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24893049     DOI: 10.1148/radiol.14132921

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  59 in total

Review 1.  Imaging of distant metastases of prostate cancer.

Authors:  Filippo Pesapane; Marcin Czarniecki; Matteo Basilio Suter; Baris Turkbey; Geert Villeirs
Journal:  Med Oncol       Date:  2018-09-14       Impact factor: 3.064

2.  Prostate cancer: Can imaging accurately diagnose lymph node involvement?

Authors:  Jelle O Barentsz; Harriet C Thoeny
Journal:  Nat Rev Urol       Date:  2015-05-05       Impact factor: 14.432

Review 3.  The use of diffusion weighted imaging to evaluate pathology outside the brain parenchyma in neuroimaging studies.

Authors:  Philip Benjamin; Faraan Khan; Andrew D MacKinnon
Journal:  Br J Radiol       Date:  2017-02-14       Impact factor: 3.039

4.  Differentiating metastatic from nonmetastatic lymph nodes in cervical cancer patients using monoexponential, biexponential, and stretched exponential diffusion-weighted MR imaging.

Authors:  Qingxia Wu; Dandan Zheng; Ligang Shi; Mingbo Liu; Meiyun Wang; Dapeng Shi
Journal:  Eur Radiol       Date:  2017-05-22       Impact factor: 5.315

Review 5.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.

Authors:  Seyed Mohammadali Dadfar; Karolin Roemhild; Natascha I Drude; Saskia von Stillfried; Ruth Knüchel; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2019-01-11       Impact factor: 15.470

Review 6.  Imaging and evaluation of patients with high-risk prostate cancer.

Authors:  Marc A Bjurlin; Andrew B Rosenkrantz; Luis S Beltran; Roy A Raad; Samir S Taneja
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

7.  Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.

Authors:  Giorgio Brembilla; Paolo Dell'Oglio; Armando Stabile; Alessandro Ambrosi; Giulia Cristel; Lisa Brunetti; Anna Damascelli; Massimo Freschi; Antonio Esposito; Alberto Briganti; Francesco Montorsi; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Eur Radiol       Date:  2017-12-21       Impact factor: 5.315

8.  Magnetic resonance sentinel lymph node imaging of the prostate with gadofosveset trisodium-albumin: preliminary results in a canine model.

Authors:  Baris Turkbey; Robert F Hoyt; Harsh K Agarwal; Marcelino Bernardo; Sandeep Sankineni; Linda Johnson; Kinzya B Grant; Soroush Rais-Bahrami; Hisataka Kobayashi; Bradford J Wood; Peter A Pinto; Gary L Griffiths; Peter L Choyke
Journal:  Acad Radiol       Date:  2015-02-13       Impact factor: 3.173

9.  [PI-RADS 2.0 for Prostate MRI].

Authors:  T Franiel; M Röthke
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

10.  A urologist's perspective on prostate cancer imaging: past, present, and future.

Authors:  Arvin K George; Baris Turkbey; Subin G Valayil; Akhil Muthigi; Francesca Mertan; Michael Kongnyuy; Peter A Pinto
Journal:  Abdom Radiol (NY)       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.